[NESTLE] QoQ Quarter Result on 31-Dec-2019 [#4]

Stock
[NESTLE] NESTLE (M) BHD
Announcement Date
25-Feb-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
31-Dec-2019 [#4]
Profit Trend
QoQ- -11.53%
YoY- 6.46%
Quarter Report
Latest QR
Upcoming QR
NESTLE's Result
NESTLE's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 1,388,423 1,219,300 1,434,514 1,328,892 1,400,765 1,335,706 1,452,713 -2.96%
PBT 170,976 140,140 246,259 172,173 191,645 199,112 312,796 -33.07%
Tax -42,588 -34,607 -59,952 -40,354 -42,653 -42,225 -77,580 -32.88%
NP 128,388 105,533 186,307 131,819 148,992 156,887 235,216 -33.13%
-
NP to SH 128,388 105,533 186,307 131,819 148,992 156,887 235,216 -33.13%
-
Tax Rate 24.91% 24.69% 24.35% 23.44% 22.26% 21.21% 24.80% -
Total Cost 1,260,035 1,113,767 1,248,207 1,197,073 1,251,773 1,178,819 1,217,497 2.30%
-
Net Worth 593,284 630,805 858,270 665,979 701,155 715,224 884,064 -23.29%
Dividend
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Div 164,150 164,150 - 328,300 164,150 164,150 - -
Div Payout % 127.85% 155.54% - 249.05% 110.17% 104.63% - -
Equity
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Net Worth 593,284 630,805 858,270 665,979 701,155 715,224 884,064 -23.29%
NOSH 234,500 234,500 234,500 234,500 234,500 234,500 234,500 0.00%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin 9.25% 8.66% 12.99% 9.92% 10.64% 11.75% 16.19% -
ROE 21.64% 16.73% 21.71% 19.79% 21.25% 21.94% 26.61% -
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
RPS 592.08 519.96 611.73 566.69 597.34 569.60 619.49 -2.96%
EPS 54.75 45.00 79.45 56.21 63.54 66.90 100.31 -33.13%
DPS 70.00 70.00 0.00 140.00 70.00 70.00 0.00 -
NAPS 2.53 2.69 3.66 2.84 2.99 3.05 3.77 -23.29%
Adjusted Per Share Value based on latest NOSH - 234,500
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
RPS 592.08 519.96 611.73 566.69 597.34 569.60 619.49 -2.96%
EPS 54.75 45.00 79.45 56.21 63.54 66.90 100.31 -33.13%
DPS 70.00 70.00 0.00 140.00 70.00 70.00 0.00 -
NAPS 2.53 2.69 3.66 2.84 2.99 3.05 3.77 -23.29%
Price Multiplier on Financial Quarter End Date
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Date 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 28/06/19 29/03/19 -
Price 141.40 139.90 136.70 147.00 145.70 149.10 146.80 -
P/RPS 23.88 26.91 22.35 25.94 24.39 26.18 23.70 0.50%
P/EPS 258.27 310.87 172.06 261.51 229.32 222.86 146.35 45.88%
EY 0.39 0.32 0.58 0.38 0.44 0.45 0.68 -30.90%
DY 0.50 0.50 0.00 0.95 0.48 0.47 0.00 -
P/NAPS 55.89 52.01 37.35 51.76 48.73 48.89 38.94 27.15%
Price Multiplier on Announcement Date
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Date 10/11/20 25/08/20 05/05/20 25/02/20 12/11/19 27/08/19 23/04/19 -
Price 141.00 140.70 139.60 142.00 145.40 149.10 145.40 -
P/RPS 23.81 27.06 22.82 25.06 24.34 26.18 23.47 0.96%
P/EPS 257.54 312.64 175.71 252.61 228.85 222.86 144.96 46.53%
EY 0.39 0.32 0.57 0.40 0.44 0.45 0.69 -31.56%
DY 0.50 0.50 0.00 0.99 0.48 0.47 0.00 -
P/NAPS 55.73 52.30 38.14 50.00 48.63 48.89 38.57 27.72%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment